Stockholders Approve Board Declassification and New Bylaws
A sits 15% above its 52-week low of $96.43 on elevated volume (1.9× avg).
Summary
Agilent Technologies' stockholders approved a phased declassification of the Board of Directors and related bylaw amendments, improving corporate governance.
Key Events · Corporate Governance and Compliance · A
-
Board Declassification Approved
Stockholders approved the Fourth Amended and Restated Certificate of Incorporation, which declassifies the Board of Directors over a three-year period, enhancing director accountability.
-
Bylaws Amended for Governance Changes
The Board also approved Fourth Amended and Restated Bylaws to align with the declassification, allowing for director removal with or without cause from the 2029 annual meeting.
-
Annual Meeting Results Confirmed
All proposals at the Annual Meeting on March 18, 2026, including director elections, executive compensation, and auditor appointment, were approved by stockholders.
Analysis · A · Industrial Applications And Services
The company's stockholders approved amendments to the Certificate of Incorporation and Bylaws, initiating a three-year phased declassification of the Board of Directors. This change enhances director accountability by moving towards annual elections for all board members and allows for director removal with or without cause after the 2029 annual meeting. This is a positive development for corporate governance and shareholder rights.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, A was trading at $111.30 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $31.5B. The 52-week trading range was $96.43 to $160.27. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.